Latest News
A team of investigators created a polygenic score that could identify a subset of the population at increased risk of developing cirrhosis.
While DAAs have improved the treatment of chronic HCV infection by eliciting higher rates of sustained virologic response, they also interact with a number of agents that could potentially limit their effectiveness.
Increased utilization of HCV-positive liver allografts for LT is seen as one of the ways to counter national organ shortages, so researchers set out to better characterize the allografts that come from HCV-positive donors from specific regions.
A team of researchers sought to determine whether neighborhood deprivation affected outcomes in pediatric patients having undergone hepatic transplantation.
A team of investigators sought to identify the accuracy of diagnostic tools for the detection of nonalcoholic fatty liver disease in adolescent patients.
In their presentation at The Liver Meeting, a team of investigators from the University of California, San Francisco sought to assess pregnancy outcomes in women with autoimmune hepatitis.
The American Gastroenterological Association commissioned an expert review to identify best practice advice for treating patients with nonalcoholic fatty liver disease.
Investigators sought to identify factors at the US county level that contribute to liver-related mortality.
A team of investigators sought to assess the impact of treatment with beta-blockers on systemic inflammation in individuals with advanced chronic liver disease.
A team of investigators sought to determine the impact of social and economic inequities on racial and ethnic minority individuals with chronic liver disease and COVID-19.
An international team of investigators conducted a multicenter, prospective, observational study to identify factors contributing to acute decompensation of cirrhosis.
The US Preventive Services Task Force concludes that screening adults and adolescents at increased risk for hepatitis B virus infection has moderate net benefit.
Investigators tested the safety and efficacy of the glucagon-like peptide-1 receptor agonist semaglutide in patients with nonalcoholic steatohepatitis and liver fibrosis.
Investigators of the national study compared early postoperative outcomes of patients who received liver grafts from donors with diabetes mellitus (DM) vs those who received grafts from donors without DM.
The COVID-19 systematic emergency response has led to a decrease in hepatitis C virus testing and identification.
Investigators compared the efficacy of a personalized dosimetry method targeting the index lesion with the standard approach targeting the perfused lobe.
Investigators evaluated the incidence of HCC in the absence of cirrhosis in Black patients with HCV.
Investigators compared a carbohydrate-restricted diet with a low-calorie diet to determine which more effectively reduced hepatic triglyceride content in children with nonalcoholic fatty liver disease.
The researchers found the median age at diagnosis was 57 years, with cirrhosis etiology most commonly resulting from nonalcoholic fatty liver disease.
Investigators evaluated the long-term efficacy of bariatric surgery for patients with non-alcoholic steatohepatitis.
